The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Relay Therapeutics, Inc(NASDAQ:RLAY) 
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company's lead product candidates include RLY-1971, an oral small...
Website: http://www.relaytx.com
Full Time Employees: 132
CEO: Sanjiv K. Patel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Relay Therapeutics Days Payable Outstanding ttm (DPO)
Relay Therapeutics Days Receivable Outstanding ttm (DSO)
Relay Therapeutics Op Cashflow Per Share ttm
Relay Therapeutics Free Cashflow Per Share ttm
Relay Therapeutics Cash Per Share ttm
Relay Therapeutics P/S ratio ttm
Relay Therapeutics (GAAP) P/E ratio ttm
Relay Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.